Skip to main content
GeneOne Life Science, Inc. logo

GeneOne Life Science, Inc. — Investor Relations & Filings

Ticker · 011000 ISIN · KR7011000007 KO Professional, scientific and technical activities
Open in API
Filings indexed 490 across all filing types
Latest filing 2025-08-08 Legal Proceedings Report
Country KR South Korea
Listing KO 011000

About GeneOne Life Science, Inc.

https://www.genels.com/en/

GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.

Recent filings

Filing Released Lang Actions
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a legal proceeding ('소송등의판결ㆍ결정'), specifically the withdrawal of a request for permission to convene an extraordinary general meeting. It details the court case, the parties involved, and the outcome (withdrawal of the application). This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2025-08-08 Korean
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a legal proceeding ('소송등의판결ㆍ결정'), specifically the withdrawal of a petition for inspection of books and records ('장부등열람허용가처분'). It details the court, case number, and the outcome of the legal matter. This falls directly under the category of legal proceedings and regulatory disclosures regarding litigation.
2025-08-08 Korean
소송등의판결ㆍ결정
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a court decision ('소송등의판결ㆍ결정') concerning the appointment of an inspector ('검사인선임') for an upcoming extraordinary general meeting of shareholders. This relates to legal proceedings and regulatory disclosures regarding corporate governance and litigation. As it specifically details a court ruling on a legal matter, it falls under the 'Legal Proceedings Report' category.
2025-08-07 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Extraordinary General Meeting' (임시주주총회 소집공고) issued by Genexine (진원생명과학). It contains detailed information regarding the meeting agenda, including proposed amendments to the articles of association, election of directors and auditors, and voting procedures (including electronic voting). This document is a formal proxy statement and meeting notice sent to shareholders to solicit votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-08-05 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding an upcoming Extraordinary General Meeting (EGM), including voting procedures, electronic voting instructions, and proposed agenda items such as amendments to the Articles of Incorporation and the election of directors. This document is a formal proxy solicitation statement sent to shareholders to request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-08-05 Korean
소송등의제기ㆍ신청(경영권분쟁소송)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding ('소송 등의 제기ㆍ신청') involving a management dispute ('경영권 분쟁 소송') at GeneOne Life Science. It details the case name, the parties involved, the nature of the claim (appointment of temporary directors), and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant legal matters involving the company.
2025-07-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.